Stock Analysis on Net
Stock Analysis on Net

CVS Health Corp. (NYSE:CVS) 

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data

CVS Health Corp., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Accounts payable 6.22 5.71 5.49 5.97 5.92 5.35 5.23 6.50 6.02 5.75 5.47 5.38 5.41 4.78 4.71 4.83 5.01 4.21 4.43 4.72 4.29 4.18 3.77
Pharmacy claims and discounts payable 9.47 9.58 8.92 9.16 8.55 8.16 8.38 8.51 8.29 7.99 7.98 7.44 7.62 7.45 7.09 6.85 6.75 6.60 6.70 6.11 5.95 5.45 5.38
Health care costs payable 6.04 5.50 5.75 4.82 4.99 4.80 4.55 4.56 4.48 4.52 4.41 3.78 3.78 3.64 3.60 3.44 3.26 3.13 3.29 3.09 3.19 3.15 3.05
Policyholders’ funds 0.36 0.42 0.43 0.53 0.57 0.56 0.60 0.66 0.71 0.71 1.78 1.85 1.89 1.98 1.93 1.85 1.70 1.54 1.35 1.34 1.33 1.33 1.24
Accrued expenses 7.99 8.38 8.95 8.89 8.98 9.13 8.99 8.21 8.40 7.70 7.14 7.58 6.87 6.41 6.23 6.17 6.15 6.64 5.89 5.45 5.28 4.82 4.75
Other insurance liabilities 0.42 0.41 0.46 0.46 1.89 1.95 2.08 0.50 1.97 0.52 0.60 0.56 0.55 0.59 0.67 0.67 0.66 0.70 0.77 0.82 0.81 0.82 0.88
Current portion of operating lease liabilities 0.76 0.76 0.76 0.70 0.69 0.68 0.70 0.74 0.73 0.81 0.79 0.71 0.77 0.77 0.78 0.71 0.77 0.75 0.76 0.72 0.82 0.82 0.82
Short-term debt 0.32 0.00 1.09 0.08 0.00 0.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.11 0.00 0.00 0.00 0.11 0.00 0.49 0.20 1.37
Current portion of long-term debt 1.95 1.48 1.49 1.11 0.85 0.56 0.74 0.78 0.59 1.75 1.81 1.80 0.66 0.03 1.05 2.36 2.34 3.48 2.53 1.70 1.72 1.78 1.77
Liabilities held for sale 0.00 0.00 0.00 0.00 0.00 0.08 0.09 0.10 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Current liabilities 33.53% 32.23% 33.36% 31.71% 32.45% 31.67% 31.36% 30.55% 31.32% 29.73% 29.96% 29.10% 27.55% 25.66% 26.18% 26.88% 26.64% 27.05% 25.82% 23.96% 23.87% 22.56% 23.04%
Long-term operating lease liabilities, excluding current portion 6.04 6.15 6.30 6.42 6.54 6.64 6.92 7.36 7.43 7.60 7.64 7.80 7.86 8.01 8.10 8.13 7.94 7.90 8.12 8.51 8.55 8.61 8.63
Long-term debt, excluding current portion 23.70 24.81 23.10 23.48 23.79 24.56 23.59 22.11 21.99 22.06 22.36 22.31 24.20 25.65 25.81 25.66 26.43 26.96 28.50 29.08 29.17 30.58 30.89
Deferred income taxes 1.44 1.60 1.68 1.73 1.69 1.83 1.71 1.70 1.52 2.37 2.50 2.69 2.69 2.84 2.88 2.94 3.11 3.03 3.09 3.28 3.31 3.37 3.43
Separate accounts liabilities 1.32 1.26 1.31 1.30 1.27 1.31 1.35 1.41 1.44 1.80 2.01 2.18 2.17 2.11 2.04 2.12 2.06 1.97 1.97 2.00 2.09 1.95 1.85
Other long-term insurance liabilities 2.04 2.00 2.07 2.19 2.12 2.26 2.37 2.68 2.67 2.73 2.73 2.75 2.79 2.91 2.99 3.04 3.06 3.09 3.18 3.34 3.43 3.64 3.66
Other long-term liabilities 2.17 2.19 2.48 2.49 2.48 2.53 2.79 2.95 2.93 0.93 0.96 0.82 0.98 1.00 1.01 1.02 1.08 0.98 0.92 0.97 0.99 1.15 1.19
Long-term liabilities 36.72% 38.02% 36.95% 37.60% 37.90% 39.13% 38.73% 38.21% 37.97% 37.48% 38.20% 38.55% 40.68% 42.52% 42.83% 42.91% 43.69% 43.93% 45.79% 47.19% 47.54% 49.30% 49.66%
Total liabilities 70.25% 70.25% 70.31% 69.31% 70.35% 70.81% 70.09% 68.76% 69.29% 67.21% 68.16% 67.65% 68.23% 68.18% 69.01% 69.79% 70.33% 70.97% 71.61% 71.15% 71.41% 71.86% 72.70%
Preferred stock, par value $0.01; none issued or outstanding 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, par value $0.01, and capital surplus 19.61 19.55 19.70 19.62 19.43 19.45 20.18 21.11 20.78 20.79 20.47 20.33 20.07 20.33 20.35 20.16 19.92 19.65 20.02 20.67 20.83 20.89 20.76
Treasury stock, at cost -14.58 -14.62 -14.72 -13.55 -13.46 -13.57 -14.12 -13.96 -13.12 -13.21 -12.94 -12.09 -11.99 -12.22 -12.24 -12.21 -12.09 -11.99 -12.22 -12.69 -12.81 -12.91 -12.84
Retained earnings 24.58 24.87 24.77 24.67 24.01 23.54 24.13 24.60 23.60 25.50 24.26 23.56 23.10 23.07 22.30 21.52 21.18 20.71 20.14 20.28 20.00 19.71 19.05
Accumulated other comprehensive income (loss) 0.08 -0.13 -0.14 -0.12 -0.40 -0.34 -0.37 -0.64 -0.70 -0.43 -0.08 0.41 0.46 0.51 0.45 0.61 0.54 0.52 0.30 0.46 0.43 0.31 0.20
Total CVS Health shareholders’ equity 29.69% 29.68% 29.62% 30.62% 29.58% 29.08% 29.83% 31.11% 30.57% 32.65% 31.70% 32.22% 31.64% 31.68% 30.86% 30.08% 29.54% 28.88% 28.24% 28.71% 28.45% 27.99% 27.16%
Noncontrolling interests 0.06 0.07 0.07 0.07 0.07 0.11 0.08 0.13 0.14 0.14 0.13 0.13 0.13 0.14 0.14 0.14 0.13 0.14 0.14 0.14 0.14 0.14 0.15
Total shareholders’ equity 29.75% 29.75% 29.69% 30.69% 29.65% 29.19% 29.91% 31.24% 30.71% 32.79% 31.84% 32.35% 31.77% 31.82% 30.99% 30.21% 29.67% 29.03% 28.39% 28.85% 28.59% 28.14% 27.30%
Total liabilities and shareholders’ equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. CVS Health Corp. current liabilities as a percentage of total liabilities and shareholders’ equity decreased from Q1 2024 to Q2 2024 but then increased from Q2 2024 to Q3 2024 exceeding Q1 2024 level.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. CVS Health Corp. long-term liabilities as a percentage of total liabilities and shareholders’ equity increased from Q1 2024 to Q2 2024 but then decreased significantly from Q2 2024 to Q3 2024.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. CVS Health Corp. total liabilities as a percentage of total liabilities and shareholders’ equity decreased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.
Total CVS Health shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. CVS Health Corp. total CVS Health shareholders’ equity as a percentage of total liabilities and shareholders’ equity increased from Q1 2024 to Q2 2024 and from Q2 2024 to Q3 2024.